Neilsen Gazo, Cherie Chu
Cite
Gazo N, Chu C. Pharmacotherapy Interventions in Ventilator Care Bundles for Preventing VAP in Adults: A Literature Review. J Mech Vent 2025; 6(2):.88-95.
Abstract
Care bundles have been introduced into practice to prevent ventilator-associated pneumonia (VAP) in critically ill adults. The Institute for Healthcare Improvement (IHI) proposed a worldwide implementation of the “IHI ventilator bundle” consisting of interventions to reduce the rate of VAP. Updates to these clinical practice bundles occur based on new evidence yet change within institutions is lagging. This review aims to discuss the latest updates in clinical evidence on the pharmacotherapy included in these bundles to aid institutional quality improvement measures.
The 2022 Society for Healthcare Epidemiology (SHEA) practice recommendations for preventing VAP were used to identify key pharmacotherapy interventions that are commonly incorporated into hospital care bundles. Three interventions were focused on for this review: (1) Multimodal sedation and analgesia strategies; (2) Oral care with chlorhexidine; and (3) Stress ulcer prophylaxis. A comprehensive literature search was conducted utilizing PubMed, focusing on MeSH terms involving the interventions identified for further review. Literature published from August 2021 to September 2024 was focused on for this project. Findings from these studies were reviewed, summarized, and compared alongside the corresponding 2022 SHEA/IDSA/APIC update recommendations to either reinforce or challenge current VAP bundle practices.
This literature review identified a correlation with the pharmacotherapy interventions recommended in the 2022 SHEA/IDSA/APIC update on current VAP bundle practices. The findings support the preferential use of non-benzodiazepine sedatives associated with better clinical outcomes. Additionally, chlorhexidine for oral care with toothbrushing is not recommended due to a lack of strong evidence supporting its effectiveness in reducing VAP rates. Conflicting evidence regarding stress-ulcer prophylaxis remains, warranting the need for further high-quality studies to draw definitive conclusions. Overall, healthcare facilities should ultimately continue to prioritize quality improvement and stay informed on the latest recommendations to effectively prevent VAP.
Keywords: Ventilator associated pneumonia, ventilator bundle, sedation, stress ulcer prophylaxis
References
| 1. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006; 19(4):637-657. https://doi.org/10.1128/CMR.00051-05 PMid:17041138 PMCid:PMC1592694 | |||
| 2. Albin OR, Admon AJ. Accurately measuring preventable ventilator-associated pneumonia deaths using observational data: It’s about Time. Ann Am Thorac Soc 2021; 18(5):777-779. https://doi.org/10.1513/AnnalsATS.202102-126ED PMid:33929311 PMCid:PMC8086539 | |||
| 3. Mastrogianni M, Katsoulas T, Galanis P, et al. The Impact of care bundles on ventilator-associated pneumonia (VAP) prevention in adult ICUs: A systematic review. Antibiotics (Basel) 2023; 12(2):227. https://doi.org/10.3390/antibiotics12020227 PMid:36830138 PMCid:PMC9952750 | |||
| 4. Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2022; 43(6):687-713. https://doi.org/10.1017/ice.2022.88 PMid:35589091 PMCid:PMC10903147 | |||
| 5. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46(9):e825-e873. https://doi.org10.1097/CCM.0000000000003299 | |||
| 6. Fraser GL, Devlin JW, Worby CP, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 2013; 41(9 Suppl 1):S30-S38. https://doi.org/10.1097/CCM.0b013e3182a16898 PMid:23989093 | |||
| 7. Hughes CG, Mailloux PT, Devlin JW, et al. Dexmedetomidine or Propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med 2021; 384(15):1424-1436. https://doi.org/10.1056/NEJMoa2024922 PMid:33528922 PMCid:PMC8162695 | |||
| 8. Lewis K, Piticaru J, Chaudhuri D, et al. Safety and efficacy of Dexmedetomidine in acutely ill adults requiring noninvasive ventilation: A systematic review and meta-analysis of randomized trials. Chest 2021; 159(6):2274-2288. https://doi.org/10.1016/j.chest.2020.12.052 PMid:33434496 PMCid:PMC8579314 | |||
| 9. Zhao T, Wu X, Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2020; 12(12):CD008367. https://doi.org/10.1002/14651858.CD008367.pub4 PMid:33368159 PMCid:PMC8111488 | |||
| 10. Sozkes S, Sozkes S. Use of toothbrushing in conjunction with chlorhexidine for preventing ventilator-associated pneumonia: a random-effect meta-analysis of randomized controlled trials. International Journal of Dental Hygiene 2023; 21(2):389-339 https://doi.org/10.1111/idh.12560 PMid:34687588 | |||
| 11. Price R, MacLennan G, Glen J. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014; 348:g2197. https://doi.org/10.1136/bmj.g2197 PMid:24687313 PMCid:PMC3970764 | |||
| 12. Klompas M, Speck K, Howell MD, et al. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014; 174:751-761. https://doi.org/10.1001/jamainternmed.2014.359 PMid:24663255 | |||
| 13. Deschepper M, Waegeman W, Eeckloo K, et al. Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med 2018; 44:1017-1026. https://doi.org/10.1007/s00134-018-5171-3 PMid:29744564 PMCid:PMC6061438 | |||
| 14. Hua F, Xie H, Worthington HV, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2016; 10:CD008367. https://doi.org/10.1002/14651858.CD008367.pub3 | |||
| 15. Dale CM, Rose L, Carbone S, et al. Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped-wedge cluster-randomized controlled trial. Intensive Care Med 2021; 47:1295-1302. https://doi.org/10.1007/s00134-021-06475-2 PMid:34609548 PMCid:PMC8490143 | |||
| 16. Barbateskovic M, Marker S, Granholm A, et al. Stress ulcer prophylaxis with proton pump inhibitors or histamine-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 2019; 45:143-158. https://doi.org/10.1007/s00134-019-05526-z PMid:30680444 | |||
| 17. Reynolds PM, MacLaren R. Re-evaluating the utility of stress ulcer prophylaxis in the critically ill patient: a clinical scenario-based meta-analysis. Pharmacotherapy 2019; 39:408-420. https://doi.org/10.1002/phar.2172 PMid:30101529 | |||
| 18. Marik PE, Vasu T, Hirani A, et al. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Critical Care Med 2010; 38:2222-2228. https://doi.org/10.1097/CCM.0b013e3181f17adf PMid:20711074 | |||
| 19. Alhazzani W, Alenezi F, Jaeschke RZ, et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013; 41:693-705. https://doi.org/10.1097/CCM.0b013e3182758734 PMid:23318494 | |||
| 20. Deliwala SS, Hamid K, Goyal H, et al. Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis and trial sequential analysis. J Clin Gastroenterol 2022; 56:204-217. https://doi.org/10.1097/MCG.0000000000001562 PMid:34049377 | |||
| 21. Garcia R, Salluh JIF, Andrade TR, et al. A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients. J Crit Care 2021; 64:91-99. https://doi.org/10.1016/j.jcrc.2021.04.001 PMid:33838522 | |||
| 22. Sun W, Yan Y, Hu S, et al. The effects of midazolam or propofol plus fentanyl on ICU mortality: a retrospective study based on the MIMIC-IV database. Ann Transl Med 2022; 10(4):219. https://doi.org/10.21037/atm-22-477 PMid:35280412 PMCid:PMC8908132 | |||
| 23. Kong X, Wu Y, Wen B, et al. Effect of stress ulcers prophylaxis, sedative and statin on ventilator-associated pneumonia: a retrospective analysis based on MIMIC database. Front Pharmacol 2022; 13:921422. https://doi.org/10.3389/fphar.2022.921422 | |||
| PMID: 35795560, PMCID: PMC9251373 | |||
| 24. Shi X, Zhang J, Sun Y, et al. Effect of different sedatives on the prognosis of patients with mechanical ventilation: a retrospective cohort study based on MIMIC-IV database. Front Pharmacol 2024; 15:1301451. https://doi.org/10.3389/fphar.2024.1301451 PMid:39092229 PMCid:PMC11291308 | |||
| 25. Triamvisit S, Wongprasert W, Puttima C, et al. Effect of modified care bundle for prevention of ventilator-associated pneumonia in critically-ill neurosurgical patients. Acute Crit Care 2021; 36(4):294-299. https://doi.org/10.4266/acc.2021.00983 PMid:35263824 PMCid:PMC8907469 | |||
| 26. Vieira PC, de Oliveira RB, da Silva Mendonça TM. Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles? Med Intensiva (Engl Ed) 2022; 46(5):259-268. https://doi.org/10.1016/j.medin.2020.09.009 | |||
| 27. De Cassai A, Pettenuzzo T, Busetto V, et al. Chlorhexidine is not effective at any concentration in preventing ventilator-associated pneumonia: a systematic review and network meta-analysis. J Anesth Analg Crit Care 2024; 4(1):30. https://doi.org/10.1186/s44158-024-00166-2 PMid:38702835 PMCid:PMC11067293 | |||
| 28. Cruz JC, Martins CK, Piassi JEV, et al. Does chlorhexidine reduce the incidence of ventilator-associated pneumonia in ICU patients? A systematic review and meta-analysis. Med Intensiva (Engl Ed). 2023; 47(8):437-444. https://doi.org/10.1016/j.medin.2022.10.002 PMid:36464582 | |||
| 29. Emami Zeydi A, Parvizi A, Haddadi S, et al. Effect of Oral Care with Povidone-Iodine in the prevention of ventilator-associated pneumonia; A systematic review and meta-analysis. Arch Acad Emerg Med 2023; 11(1):e31. https://doi.org/10.22037/aaem.v11i1.1874 PMID: 37215234, PMCID: PMC10197909 | |||
| 30. MacLaren R, Dionne J, Granholm, A, et al. Society of Critical Care Medicine and American Society of Health-System Pharmacists guideline for the prevention of stress-related gastrointestinal bleeding in critically ill adults. Crit Care Med 2024; 52(8):e421-e430. https://doi.org/10.1097/CCM.0000000000006330 PMid:39007578 | |||
| 31. Cook D, Deane A, Lauzier F, et al. Stress ulcer prophylaxis during invasive mechanical ventilation. N Engl J Med 2024; 391(1):9-20. https://doi.org/10.1056/NEJMoa2404245 PMid:38875111 |
